Altium Capital Management LP Infla Rx N.V. Transaction History

Altium Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.25 - $3.03 $362,713 - $488,454	-161,206 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$2.72 - $4.04 $1.67 Million - $2.48 Million	-613,394 Reduced 79.19%	161,206 $479,000
Q1 2021 May 06, 2021	BUY	$3.62 - $6.34 $2.8 Million - $4.91 Million	774,600 New	774,600 $3.02 Million

13.8M

12.9K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $76.5M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.